Bronchiolitis risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 18: | Line 18: | ||
===Common risk factors in adult=== | ===Common risk factors in adult=== | ||
* Exposure to cigarette smoke | *Exposure to cigarette smoke. | ||
* Living in crowded conditions | *Living in crowded conditions. | ||
*Immunocompromised adult patients. | |||
*Older adults, especially those with underlying heart or lung disease. | |||
==References== | ==References== | ||
Revision as of 18:28, 1 June 2017
|
Bronchiolitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bronchiolitis risk factors On the Web |
|
American Roentgen Ray Society Images of Bronchiolitis risk factors |
|
Risk calculators and risk factors for Bronchiolitis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Common risk factors in the development of bronchiolitis include exposure to cigarette smoke, age < 6 months, lack of breast-feeding, prematurity, and crowded living conditions.
Risk Factors
Common risk factors in infants and children
The following infants and children cases are at higher risk to be infected with bronchiolitis:[1][2][3]
- Premature infants as the maternal transfer of immunoglobulins occur in the last trimester
- Young children infected with congenital heart diseases are at high risk due to decreased cardiac output.[4] These diseases include:
- Pulmonary hypertension
- Congestive heart failure
- Lack of breast-feeding
- Children and infants infected by chronic lung disease
- Immunocompromised children due to a medical condition or medical treatment
Common risk factors in adult
- Exposure to cigarette smoke.
- Living in crowded conditions.
- Immunocompromised adult patients.
- Older adults, especially those with underlying heart or lung disease.
References
- ↑ CDC https://www.cdc.gov/rsv/about/transmission.html Accessed on June 1, 2017
- ↑ Meissner HC (2016). "Viral Bronchiolitis in Children". N Engl J Med. 374 (1): 62–72. doi:10.1056/NEJMra1413456. PMID 26735994.
- ↑ Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G (2012). "Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006". Pediatr Infect Dis J. 31 (1): 5–9. doi:10.1097/INF.0b013e31822e68e6. PMID 21817948.
- ↑ Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH; et al. (2003). "Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease". J Pediatr. 143 (4): 532–40. PMID 14571236.